This schematic shows that internal validity (green line) is higher than external validity (orange) and translational validity (blue) at the start of a preclinical research trajectory (left), and …
RPCB | BRI | CPS | |
---|---|---|---|
Selection of samples to be replicated | Main findings from 50 high impact citations/publications in cancer research | Replication of 60–100 experiments from research articles of Brazilian studies in different clinical areas | Two-step review process of proposals results in twelve projects |
Selection of experiment | Main finding from published studies | Experiments using five pre-defined methods | Own experiments |
Replicate own results | No | No | Yes |
Exact Protocols | Yes (consulting original authors) | No | Yes |
Blind to initial results | No | Yes | No |
Pre-registration | Pre-registered study and individual Replication Protocols | Yes | Yes |
Multi-site replication | No | Yes | Yes |